Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rotraud Wieser
Observed names:
R Wieser,
R. Wieser,
ROTRAUD WIESER,
Wieser, R.,
Wieser, Rotraud
Institutions:
Ludwig Boltzmann Institute for Hematology and Oncology,
Medical University of Vienna
Observed institutions:
University of Vienna,
Memorial Sloan Kettering Cancer Center,
Howard Hughes Medical Institute,
Johannes Gutenberg University Mainz,
Comprehensive Cancer Center Vienna,
Ludwig Boltzmann Institute for Hematology and Oncology,
Medical University of Vienna
show all 7
ORCID:
0000-0003-4384-6658
Observed ORCID:
0000-0003-4384-6658
OpenAlex ID:
A5041101614
Works
104
Awards
10
Mechanism of activation of the TGF-β receptor
1994
·
Jeffrey L. Wrana
, Liliana Attisano
, et al.
·
Nature
·
2,661
TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development
1999
·
Juan Juan Yin
, Katri Selander
, et al.
·
Journal of Clinical Investigation
·
1,097
PDF
GS domain mutations that constitutively activate T beta R‐I, the downstream signaling component in the TGF‐beta receptor complex.
1995
·
R. Wieser
, J.L. Wrana
, et al.
·
The EMBO Journal
·
791
Distinct roles of type I bone morphogenetic protein receptors in the formation and differentiation of cartilage
1997
·
Hongyan Zou
, Rotraud Wieser
, et al.
·
Genes & Development
·
548
PDF
Type I Receptors Specify Growth-Inhibitory and Transcriptional Responses to Transforming Growth Factor β and Activin
1994
·
J Cárcamo
, F M Weis
, et al.
·
Molecular and Cellular Biology
·
412
Embryonic lethality and fetal liver apoptosis in mice lacking the c‐raf‐1 gene
2001
·
Mario Mikula
, Martin Schreiber
, et al.
·
The EMBO Journal
·
362
PDF
Signaling Activity of Transforming Growth Factor β Type II Receptors Lacking Specific Domains in the Cytoplasmic Region
1993
·
R Wieser
, L Attisano
, et al.
·
Molecular and Cellular Biology
·
242
Heat shock factor-independent heat control of transcription of the CTT1 gene encoding the cytosolic catalase T of Saccharomyces cerevisiae
1991
·
R. Wieser
, G. Adam
, et al.
·
Journal of Biological Chemistry
·
176
The oncogene and developmental regulator EVI1: Expression, biochemical properties, and biological functions
2007
·
Rotraud Wieser
·
Gene
·
164
Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia
2017
·
Hubert Hackl
, Ksenia Astanina
, et al.
·
Journal of Hematology & Oncology
·
141
PDF
Negative regulation of transcription of the Saccharomyces cerevisiae catalase T (CTT1) gene by cAMP is mediated by a positive control element.
1991
·
T. Belazzi
, A. Wagner
, et al.
·
The EMBO Journal
·
124
PDF
Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletion
2006
·
V Sagaster
, H Ludwig
, et al.
·
Leukemia
·
121
Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1
2004
·
Andrea Zatkova
, Ludwine Messiaen
, et al.
·
Human Mutation
·
110
Control of Saccharomyces cerevisiae Catalase T Gene ( CTT1 ) Expression by Nutrient Supply via the RAS -Cyclic AMP Pathway
1989
·
P H Bissinger
, R Wieser
, et al.
·
Molecular and Cellular Biology
·
103
Clinical significance of genetic aberrations in secondary acute myeloid leukemia
2012
·
Jelena D. Milosevic
, Ana Puda
, et al.
·
American Journal of Hematology
·
95
PDF
Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma
2004
·
H Kaufmann
, J Ackermann
, et al.
·
Leukemia
·
91
Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP
2016
·
Stefan Hatzl
, Olivia Geiger
, et al.
·
Cancer Research
·
67
The leukaemia‐associated transcription factors EVI‐1 and MDS1/EVI1 repress transcription and interact with histone deacetylase
2001
·
Ursula Vinatzer
, Jan Taplick
, et al.
·
British Journal of Haematology
·
64
Expression and prognostic significance of different mRNA 5′‐end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration
2008
·
Katja Haas
, Michael Kundi
, et al.
·
Genes Chromosomes and Cancer
·
60
SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness
2019
·
Chi Huu Nguyen
, Tobias Glüxam
, et al.
·
Scientific Reports
·
58
PDF
The transforming growth factor-β signaling pathway in tumorigenesis
2001
·
Rotraud Wieser
·
Current Opinion in Oncology
·
56
Overexpression of primary microRNA 221/222 in acute myeloid leukemia
2013
·
Anna Rommer
, Katarina Steinleitner
, et al.
·
BMC Cancer
·
53
PDF
A gene expression profile associated with relapse of cytogenetically normal acute myeloid leukemia is enriched for leukemia stem cell genes
2014
·
Hubert Hackl
, Katarina Steinleitner
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
47
PDF
Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemia
2002
·
Ursula Vinatzer
, Christine Mannhalter
, et al.
·
Genes Chromosomes and Cancer
·
44
Regulation of the expression of the oncogene EVI1 through the use of alternative mRNA 5′-ends
2005
·
Metin Aytekin
, Ursula Vinatzer
, et al.
·
Gene
·
40
Show more works
View as search
Works count:
104
Citation count:
8,426
H-index:
30
I10-index:
53
Year
Topic
Type